13-cisretinoic acid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 13-cisretinoic acid, covering 2023-06-15 to 2023-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Double Blind Phase III Trial of Effects of Low Dose 13-Cisretinoic Acid on Prevention of Second Primaries in Stages I-II Head and Neck Cancer [Phase 3]